GlassScriptPhysician profile
Shafayet Alam
NPI 1558776450
$1,338.50
in general payments reported to CMS, 2019-2025
9 companies · $431 in 2025
The $431 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.67 · 2024: $889 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $351.94 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Advanced Oxygen Therapy INC. | $277.78 | 2024 | Topical Oxygen Chamber For Extremities |
| Amgen INC. | $275.00 | 2024 | Tepezza |
| Acera Surgical, INC. | $168.03 | 2024-2025 | Restrata Wound Matrix |
| Solventum Corporation | $159.55 | 2024-2025 | Activ.A.C., V.A.C.Ulta, V.A.C. Veraflo |
| Smith+Nephew, INC. | $34.19 | 2024-2025 | Collagenase Santyl |
| Integra Lifesciences Corporation | $29.34 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Chiesi USA, INC. | $24.00 | 2024 | Mycapssa |
| Nevro Corp. | $18.67 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shafayet Alam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.